Loading...

VIVIMEDLAB Vivimed Labs Ltd Operational Disruptions Announcement

Vvmd

VVMD

Vivimed Labs Ltd

(VIVIMEDLAB)

2025 Announcement

CIRP Public Announcement

Regulatory compliance certi...

Regulatory Compliance

Trading Window Closure

Unaudited financial results

Board Meeting Notice

Regulatory Compliance

Pre-pack Insolvency Resolut...

Board meeting postponement

Legal proceedings

CFO Resignation

Criminal Investigation

Board meeting for results

SEBI circular compliance

Price movement clarification

Trading Window Closure

Trading suspension revocation

EGM Notice Publication

Newspaper publication

IBC Pre-pack Insolvency

Pre-pack insolvency

IBC prepack filing

Transfer Requests Update

Board Meeting Notice

Debt Assignment

Compliance Certificate

Transfer Requests Update

Transfer Requests Update

AGM Notice Dispatch

AGM Notice Publication

Compliance Certificate

Audit Qualification Update

Financial Results Published

Compliance Report

Compliance Certificate

Corporate Declaration

CFO Appointment

Compliance Certificate

Audit Qualifications Impact

Director Resignation

Board Meeting Outcome

Directors Demise

Regulatory Compliance

Compliance Certificate

Non-Compliance Announcement

Compliance Submission

Resignation of Auditors

Postponed Board Meeting

Office Address Change

Compliance Certificate

Certificate Issuance

Certificate Compliance

CFO Resignation

Compliance Certificate

Compliance Certificate Rece...

Extension of AGM

Financial Statements

Certificate Compliance

External Links:

Data:

Trading on Vivimed Labs’ equity shares will resume on December 18, 2025, after the exchanges revoked the suspension, restoring liquidity and price discovery.

AI Assistant

Vivimed Labs Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.